Cross-platform validation confirms long-read sequencing effectiveness for myotonic dystrophy type 2 repeat analysis
Researchers performed a cross-platform validation study comparing Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio) HiFi long-read sequencing for characterizing repeat expansions in myotonic dystrophy type 2 (DM2), finding high concordance between the two platforms. The study also identified a previously unreported (CCCG)n DNA motif at the 3' end of expanded alleles in the CNBP gene, adding to the known structural complexity of DM2 expansions. These findings provide a validated bioinformatic framework that could support the integration of long-read sequencing into routine clinical diagnostics for DM2 and related repeat expansion disorders.
A new preprint study on bioRxiv reports a systematic cross-platform validation of long-read sequencing (LRS) approaches for analyzing repeat expansions in myotonic dystrophy type 2 (DM2), a condition caused by expansions in the CNBP gene. Eight DM2 patient DNA samples were sequenced using both ONT and PacBio HiFi technologies following amplification-free targeted enrichment, and despite significant differences in sequencing chemistry and read coverage, the platforms showed strong agreement in estimating repeat size, somatic mosaicism, and repeat architecture. Beyond validation, the study confirmed the presence of the known (TCTG)n repeat motif and identified a novel (CCCG)n motif at the 3' end of expanded alleles, a finding that underscores the structural complexity of CNBP expansions. The researchers also developed an improved bioinformatic workflow for ONT-based repeat characterization that addresses prior limitations in motif resolution. The authors argue that this validated framework supports broader adoption of LRS technologies in molecular diagnostics for DM2 and other repeat expansion disorders, where accurate characterization of repeat structure has both diagnostic and potential prognostic relevance.
What's missing
The cohort is small (n=8 DM2 patients), which limits the generalizability of the novel (CCCG)n motif finding and the bioinformatic workflow's performance across broader patient populations. The clinical significance of the newly identified (CCCG)n motif — including whether it correlates with disease severity or progression — is not addressed. Additionally, cost and accessibility considerations for implementing these LRS workflows in routine clinical settings are not discussed.
What different sources said
- bioRxivCenter
Long-read cross-platform validation reveals novel repeat features in myotonic dystrophy type 2
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.